Jaime Bartushak

Director of Finance/CFO at CITIUS PHARMACEUTICALS, INC.

Net worth: 630 875 $ as of 2026-08-30

59 year

Health Technology

Consumer Services

Profile

Jaime Bartushak was the founder of Leonard-Meron Biosciences, Inc., founded in 2014, and held the title of Chief Financial Officer from 2014 to 2017.
Current jobs include CFO, Chief Accounting & Business Officer at Citius Pharmaceuticals, Inc. since 2017, and Chief Financial & Business Officer at Citius Oncology, Inc. since 2022.
Education history includes undergraduate and graduate degrees from New Jersey Institute of Technology.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.89%	2025-09-18	825,000 ( 0.89% )	629 475 $	2026-08-30
CITIUS PHARMACEUTICALS INC 0.01%	2026-02-12	2,414 ( 0.01% )	1 400 $	2026-08-30

Jaime Bartushak active positions

Companies	Position	Start
CITIUS PHARMACEUTICALS, INC.	Director of Finance/CFO	2017-11-26

All active positions of Jaime Bartushak

Former positions of Jaime Bartushak

Companies	Position	End
Leonard-Meron Biosciences, Inc. Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products	Founder	2017-10-31

See the detail of Jaime Bartushak's experience

Training of Jaime Bartushak

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jaime Bartushak's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company	Health Technology
New Jersey Institute of Technology New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Leonard-Meron Biosciences, Inc. Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products	Health Technology